J. Goldman & CO LP Iovance Biotherapeutics, Inc. Transaction History

J. Goldman & CO LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$4.44 - $8.79 $59,940 - $118,664	13,500 New	13,500 $61,000
Q1 2023 May 15, 2023	BUY	$5.53 - $8.22 $3.6 Million - $5.36 Million	651,664 New	651,664 $3.98 Million
Q2 2020 Aug 14, 2020	SELL	$27.21 - $41.0 $1.23 Million - $1.85 Million	-45,205 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$19.54 - $38.85 $883,305 - $1.76 Million	45,205 New	45,205 $1.35 Million

320

239M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $986M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.